Avax Techs Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Avax Techs prevailing Real Value cannot be determined due to lack of data. The current price of Avax Techs is $0.0. Our model approximates the value of Avax Techs from analyzing the firm fundamentals such as current valuation of 7.13 M, and Return On Asset of -4.57 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
0.00
Please note that Avax Techs' price fluctuation is out of control at this time. Calculation of the real value of Avax Techs is based on 3 months time horizon. Increasing Avax Techs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Avax Techs' intrinsic value may or may not be the same as its current market price of 0.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0 Real  0.0 Hype  0.0 Naive  3.3E-5
The intrinsic value of Avax Techs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avax Techs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.00
Real Value
12.70
Upside
Estimating the potential upside or downside of Avax Techs helps investors to forecast how Avax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avax Techs more accurately as focusing exclusively on Avax Techs' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.0000330.0000330.000033
Details
Hype
Prediction
LowEstimatedHigh
0.000.0012.70
Details
Naive
Forecast
LowNext ValueHigh
0.0000010.00003312.70
Details

Avax Techs Total Value Analysis

Avax Techs is presently anticipated to have valuation of 7.13 M with market capitalization of 6.42 M, debt of 3.33 M, and cash on hands of 86.4 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Avax Techs fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.13 M
6.42 M
3.33 M
86.4 K

Avax Techs Investor Information

The company had not issued any dividends in recent years. Avax Techs had 1:2 split on the 14th of May 1997. Based on the key indicators related to Avax Techs' liquidity, profitability, solvency, and operating efficiency, Avax Techs is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Avax Techs Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avax Techs has an asset utilization ratio of 24.39 percent. This implies that the Company is making $0.24 for each dollar of assets. An increasing asset utilization means that Avax Techs is more efficient with each dollar of assets it utilizes for everyday operations.

Avax Techs Profitability Analysis

The company reported the previous year's revenue of 142.5 K. Net Loss for the year was (11.99 M) with profit before overhead, payroll, taxes, and interest of 142.5 K.

About Avax Techs Valuation

The stock valuation mechanism determines Avax Techs' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Avax Techs based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avax Techs. We calculate exposure to Avax Techs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avax Techs's related companies.
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania. Avax Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people.

Additional Tools for Avax Stock Analysis

When running Avax Techs' price analysis, check to measure Avax Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avax Techs is operating at the current time. Most of Avax Techs' value examination focuses on studying past and present price action to predict the probability of Avax Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avax Techs' price. Additionally, you may evaluate how the addition of Avax Techs to your portfolios can decrease your overall portfolio volatility.